Stock MTNB MATINAS BIOPHARMA HOLDINGS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Matinas BioPharma Holdings, Inc.

Equities

MTNB

US5768101058

Market Closed - Nyse
Other stock markets
 04:00:00 2024-05-03 pm EDT 		5-day change 1st Jan Change
0.1749 USD -4.58% Intraday chart for Matinas BioPharma Holdings, Inc. -2.24% -19.10%
Apr. 30 In Vivo Efficacy of Matinas BioPharma?s Oral MAT2203 in Pulmonary Mucormycosis Published in Journal of Antimicrobial Agents and Chemotherapy CI
Mar. 27 Transcript : Matinas BioPharma Holdings, Inc., 2023 Earnings Call, Mar 27, 2024

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
MATINAS BIOPHARMA : Piper Sandler Cuts Matinas BioPharma Holdings to Neutral From Overweight, Price Target to $0.90 From $4
MT
MATINAS BIOPHARMA : HC Wainwright Adjusts Price Target on Matinas BioPharma Holdings to $3 From $4, Maintains Buy Rating
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. MTNB Stock
  4. News Matinas BioPharma Holdings, Inc.
  5. Analyst Reco.